Yi Zhang

97.1k total citations · 16 hit papers
1.3k papers, 57.3k citations indexed

About

Yi Zhang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yi Zhang has authored 1.3k papers receiving a total of 57.3k indexed citations (citations by other indexed papers that have themselves been cited), including 500 papers in Molecular Biology, 368 papers in Immunology and 363 papers in Oncology. Recurrent topics in Yi Zhang's work include Immune Cell Function and Interaction (139 papers), Immunotherapy and Immune Responses (120 papers) and MicroRNA in disease regulation (111 papers). Yi Zhang is often cited by papers focused on Immune Cell Function and Interaction (139 papers), Immunotherapy and Immune Responses (120 papers) and MicroRNA in disease regulation (111 papers). Yi Zhang collaborates with scholars based in China, United States and Canada. Yi Zhang's co-authors include Xiaoying Gu, Jiuyang Xu, Fei Zhou, Bin Cao, Yeming Wang, Guohui Fan, Ying Liu, Bin Song, Ting Yu and Jie Xiang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Yi Zhang

1.3k papers receiving 56.3k citations

Hit Papers

Clinical course and... 2001 2026 2009 2017 2020 2017 2020 2017 2020 5.0k 10.0k 15.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Zhang China 81 16.5k 14.7k 13.9k 12.8k 7.5k 1.3k 57.3k
Joseph J.�Y. Sung Hong Kong 140 23.3k 1.4× 11.6k 0.8× 13.6k 1.0× 5.2k 0.4× 2.9k 0.4× 1.3k 86.8k
Giuseppe Lippi Italy 97 5.5k 0.3× 9.7k 0.7× 6.9k 0.5× 2.4k 0.2× 4.9k 0.7× 1.7k 53.4k
George F. Gao China 93 10.8k 0.7× 28.3k 1.9× 4.4k 0.3× 7.9k 0.6× 4.3k 0.6× 744 56.2k
Pan‐Chyr Yang Taiwan 99 13.6k 0.8× 4.2k 0.3× 10.5k 0.8× 3.7k 0.3× 843 0.1× 829 39.2k
Giuseppe Remuzzi Italy 144 16.0k 1.0× 3.7k 0.3× 4.6k 0.3× 17.9k 1.4× 1.6k 0.2× 1.3k 95.1k
Ramnik J. Xavier United States 116 32.8k 2.0× 9.4k 0.6× 4.0k 0.3× 18.7k 1.5× 899 0.1× 451 62.9k
Jos H. Beijnen Netherlands 111 17.7k 1.1× 6.0k 0.4× 27.4k 2.0× 3.4k 0.3× 697 0.1× 1.5k 57.9k
Amirhossein Sahebkar Iran 127 22.9k 1.4× 2.1k 0.1× 5.0k 0.4× 8.4k 0.7× 1.3k 0.2× 1.9k 69.4k
Li Zhang China 81 12.9k 0.8× 1.3k 0.1× 7.6k 0.5× 7.1k 0.6× 2.3k 0.3× 1.9k 39.8k
Yehuda Shoenfeld Israel 115 8.2k 0.5× 5.5k 0.4× 3.0k 0.2× 20.2k 1.6× 5.4k 0.7× 1.6k 63.1k

Countries citing papers authored by Yi Zhang

Since Specialization
Citations

This map shows the geographic impact of Yi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhang more than expected).

Fields of papers citing papers by Yi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhang. The network helps show where Yi Zhang may publish in the future.

Co-authorship network of co-authors of Yi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhang. A scholar is included among the top collaborators of Yi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhang. Yi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhang, Yi, Mingjie Wang, Ling Ye, et al.. (2024). HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression. Nature Communications. 15(1). 1314–1314. 24 indexed citations
4.
Zhou, Bin, et al.. (2024). The involvement of VEGF and VEGFR in bacterial recognition and regulation of antimicrobial peptides in Eriocheir sinensis. International Journal of Biological Macromolecules. 270(Pt 1). 132242–132242. 1 indexed citations
5.
Ruan, Jingya, Huimin Li, Fan Sun, et al.. (2023). Bioactive triterpenes of jujube in the prevention of colorectal cancer and their molecular mechanism research. Phytomedicine. 110. 154639–154639. 12 indexed citations
6.
7.
Guo, Feifei, Yi Zhang, Ling Bai, & Jiuwei Cui. (2023). Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle. Cancer Letters. 570. 216328–216328. 15 indexed citations
8.
Li, Huimin, Jingya Ruan, Haiyang Yu, et al.. (2023). Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis. International Journal of Molecular Sciences. 24(24). 17538–17538. 11 indexed citations
9.
Zhang, Yi, et al.. (2023). The antibacterial activity and antibacterial mechanism analyses of an LRR-IG protein in the Chinese mitten crab, Eriocheir sinensis. International Journal of Biological Macromolecules. 234. 123732–123732. 8 indexed citations
10.
Lu, Yuyan, et al.. (2023). Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma. Immunology Letters. 258. 8–19. 3 indexed citations
11.
Yin, Liyuan, Yi Zhang, Lijuan Yin, et al.. (2021). Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells. Molecular Cancer Therapeutics. 20(12). 2527–2538. 6 indexed citations
12.
Critchley-Thorne, Rebecca J., Jon M. Davison, Jeffrey W. Prichard, et al.. (2016). A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Cancer Epidemiology Biomarkers & Prevention. 26(2). 240–248. 32 indexed citations
13.
Critchley-Thorne, Rebecca J., Lucas C. Duits, Jeffrey W. Prichard, et al.. (2016). A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus. Cancer Epidemiology Biomarkers & Prevention. 25(6). 958–968. 44 indexed citations
14.
Chen, Lin, Jie Li, Fei Wang, et al.. (2016). Tie2 Expression on Macrophages Is Required for Blood Vessel Reconstruction and Tumor Relapse after Chemotherapy. Cancer Research. 76(23). 6828–6838. 77 indexed citations
15.
Li, Yong, Shunqun Luo, Ruihua Ma, et al.. (2015). Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors. Cancer Research. 75(7). 1191–1196. 68 indexed citations
16.
Zhang, Yi, Ke Tang, Ruihua Ma, et al.. (2014). Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling. Cancer Immunology Research. 3(2). 196–205. 125 indexed citations
17.
Chen, Siqi, Long Wang, Jie Fan, et al.. (2014). Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism. Cancer Research. 75(3). 519–531. 80 indexed citations
18.
Friedline, Randall H., Hai V. Nguyen, Hardy Kornfeld, et al.. (2009). CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. The Journal of Experimental Medicine. 206(2). 421–434. 205 indexed citations
19.
Zhang, Bin, Yi Zhang, Natalie A. Bowerman, et al.. (2008). Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma. Cancer Research. 68(5). 1563–1571. 59 indexed citations
20.
Raponi, Mitch, Yi Zhang, Jack X. Yu, et al.. (2006). Gene Expression Signatures for Predicting Prognosis of Squamous Cell and Adenocarcinomas of the Lung. Cancer Research. 66(15). 7466–7472. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026